Author

B. Gabrielli

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell signaling & trafficking· 2 Research Focus:development & morphogenesis· 2 Organism:human· 2 Research Focus:chromatin & epigenetic regulation· 1 Approach:experimental assay· 1 Approach:mechanistic / dynamical model· 1

Frequent Co-Authors

A. Andrew· 1 shared A. G. Smith· 1 shared C. A. Tonnessen-Murray· 1 shared C. R. Goding· 1 shared D. Nazareth· 1 shared D. S. Hill· 1 shared E. K. Scott· 1 shared G. C. Vanwalleghem· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Andrew

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Mechanism by which Aurora B inhibitors promotes RB and p53-dependent senescence.

S. Vora, A. Andrew, R. P. Kumar, D. Nazareth, M. Fernando, M. J. Jones, Y. He, J. Hooper, N. A. McMillan, J. Urosevic, J. Saeh, J. Travers, B. Gabrielli

This study investigates how Aurora B inhibitors induce polyploidy and shows that higher ploidy states reduce long-term proliferative potential in cells with functional RB and p53.

bioRxiv · Mar 27, 2024 · PreprintCell Biology

Phenotypic melanoma heterogeneity is regulated through cell-matrix interaction-dependent changes in tumor microarchitecture

L. Spoerri, C. A. Tonnessen-Murray, G. Gunasingh, D. S. Hill, K. A. Beaumont, R. J. Jurek, J. Chauhan, G. C. Vanwalleghem, M. E. Fane, S. M. Daignault-Mill, N. Matigian, G. M. Boyle, E. K. Scott, A. G. Smith, S. J. Stehbens, , N. K. Haass

This paper shows that melanoma phenotypic heterogeneity is controlled by cell-ECM crosstalk, altering tumor microarchitecture and mechanotransduction.

bioRxiv · Jun 9, 2020 · PreprintCancer Biology